Tobias Bluhmki
Overview
Explore the profile of Tobias Bluhmki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
75
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Unseld T, Bluhmki T, Beyersmann J, Beck E, Padberg S, Stegherr R
Biom J
. 2024 Oct;
66(8):e202400083.
PMID: 39470119
Landmarking is an alternative to complex multistate models when the aim is to calculate dynamic predictions. We develop the concept of landmarking for the case of left truncation and competing...
2.
Tomeczkowski J, Heidbrede T, Leverkus F, Schmitter S, Dintsios C, Osowski U, et al.
Clin Pharmacol Ther
. 2024 May;
117(1):22-23.
PMID: 38721790
No abstract available.
3.
Stegherr R, Beyersmann J, Bramlage P, Bluhmki T
Stat Methods Med Res
. 2023 Mar;
32(5):1021-1032.
PMID: 36924264
Unmeasured baseline information in left-truncated data situations frequently occurs in observational time-to-event analyses. For instance, a typical timescale in trials of antidiabetic treatment is "time since treatment initiation", but individuals...
4.
Palmes C, Bluhmki T, Funke B, Bluhmki E
Int J Biostat
. 2022 May;
18(1):19-38.
PMID: 35641137
The two one-sided -tests (TOST) method is the most popular statistical equivalence test with many areas of application, i.e., in the pharmaceutical industry. Proper sample size calculation is needed in...
5.
Bluhmki T, Schmoor C, Finke J, Schumacher M, Socie G, Beyersmann J
Biol Blood Marrow Transplant
. 2020 Jan;
26(5):992-997.
PMID: 31927103
In most clinical oncology trials, time-to-first-event analyses are used for efficacy assessment, which often do not capture the entire disease process. Instead, the focus may be on more complex time-to-event...
6.
Kaier K, Heister T, Motschall E, Hehn P, Bluhmki T, Wolkewitz M
Epidemiol Infect
. 2019 Dec;
147:e314.
PMID: 31802726
The impact of mechanical ventilation on the daily costs of intensive care unit (ICU) care is largely unknown. We thus conducted a systematic search for studies measuring the daily costs...
7.
Philipps W, Fietz A, Meixner K, Bluhmki T, Meister R, Schaefer C, et al.
Infection
. 2019 Jul;
48(1):57-64.
PMID: 31302868
Purpose: The primary aim of our study was to assess pregnancy outcome after first-trimester exposure to fosfomycin. Methods: We performed an observational cohort study analysing prospectively ascertained pregnancies including 152...
8.
Bluhmki T, Putter H, Allignol A, Beyersmann J
Stat Med
. 2019 Jun;
38(20):3747-3763.
PMID: 31162707
We consider nonparametric and semiparametric resampling of multistate event histories by simulating multistate trajectories from an empirical multivariate hazard measure. One advantage of our approach is that it does not...
9.
Bluhmki T, Fietz A, Stegherr R, Beck E, Padberg S, Beyersmann J, et al.
Pharmacoepidemiol Drug Saf
. 2019 Mar;
28(5):616-624.
PMID: 30828912
Purpose: Observational cohort studies are essential to evaluate the risk of adverse pregnancy outcomes associated with drug intake. Besides left truncation and competing events, it is crucial to account for...
10.
Bluhmki T, Allignol A, Ruckly S, Timsit J, Wolkewitz M, Beyersmann J
Biom J
. 2018 Sep;
60(6):1135-1150.
PMID: 30198195
The expected excess length-of-stay is an established concept to assess the health and economic impact of nosocomial, that is, hospital-acquired infections such as ventilation-acquired pneumonia in intensive care. Estimation must...